Nuvasive NVM5 EMG Module recalled over sterility concerns
- Recall date
- June 10, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- NuVasive Inc recalls Nuvasive NVM5 EMG Module, REF 8020015, Rx ONLY, CE2797, Nonsterile, UDI: 00887517206633 - Product Usage: is intended fo…
- Recall number
- Z-2684-2020
- FDA classification
- Class II
- Brand / firm
- NuVasive Inc
- Sold / distributed
- US Nationwide distribution including in the states of AR, CA, IA, IL, WI. OUS: None
Why it was recalled
The NVM5 EMG Module kit intended for intraoperative neurophysiologic monitoring during spinal surgery contains incorrect component, part number 1715945, SSEP harness instead of the the correct part number 1747065, NVM5 Harness, Gen 3.5 EM. This issue can result in delay in therapy or lack of EMG neuromonitoring during surgery if the surgeon elects to proceed without the NVM5.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nuvasive NVM5 EMG Module, REF 8020015, Rx ONLY, CE2797, Nonsterile, UDI: 00887517206633 - Product Usage: is intended for intraoperative neurophysiologic monitoring during spinal surgery.
Get recall alerts
Free email alert whenever NuVasive Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: NuVasive Inc